U.S. Markets closed

WuXi PharmaTech (WX) in Focus: Stock Falls 6.4%

Zacks Equity Research

WuXi PharmaTech (Cayman) Inc. (WX) saw a big move last session, as the company’s shares fell over 6% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This continues the most recent downtrend for WX, as the stock is down nearly 15% since May 22.
 
This Medical company has seen a flat track record when it comes to current year estimate revisions, as there has been no revision on either side over the past few weeks. The consensus for earnings estimate hasn’t been in a trend either. This recent price action is discouraging, so make sure to keep a close watch on this firm in the near future, and especially on earnings estimates following the recent slump.
 
WX currently has a Zacks Rank #5 (Strong Sell) while its Earnings ESP is 0.00%.
 
Some better-ranked stocks in the Medical Drugs industry include Ariad Pharmaceuticals Inc. (ARIA), Aeolus Pharmaceuticals Inc. (AOLS) and Aerie Pharmaceuticals, Inc. (AERI). All these stocks carry a Zacks rank #2 (Buy).
 
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
 




WUXI PHARMATECH CAYMAN INC (WX): Free Stock Analysis Report

ARIAD PHARMACEUTICALS INC (ARIA): Free Stock Analysis Report

AERIE PHARMACEUTICALS INC (AERI): Free Stock Analysis Report

AEOLUS PHARMACEUTICL (AOLS): Free Stock Analysis Report


Zacks Investment Research